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Abstract 
Introduction:  
Thyroglossal duct or cyst carcinoma (TGDCCa) is uncommon. Current treatment protocols 
follow those of thyroid cancer but there is controversy over the extent of thyroid and lymph 
node surgery. Our aim was to study the presentation, treatment strategies and clinical 
outcomes in patients presenting with TGDCCa. 
Methods:  
Of 637 patients diagnosed with thyroid cancer over 15-years, 5 patients (0.8%) with TGDCCa 
were identified. Another patient was diagnosed outside this time period. Details of 
demographics, presentation, diagnosis, management and outcomes of all 6 patients were 
reviewed. 
Results:  
5 females and 1 male with a median (range) age of 41 (21-70) years were treated for 
TGDCCa. Five patients were diagnosed after initial surgery for thyroglossal cyst - cyst excision 
(n=2) ĂŶĚ^ŝƐƚƌƵŶŬ ?ƐƉƌŽĐĞĚƵƌĞ(n=3). This was followed by a total thyroidectomy (TT) in 4 of 
ƚŚĞƐĞ ƉĂƚŝĞŶƚƐ ? KŶĞ ƉĂƚŝĞŶƚ ƵŶĚĞƌǁĞŶƚ Ă ^ŝƐƚƌƵŶŬ ?Ɛ ŽƉĞƌĂƚŝŽŶ ? ƚŽƚĂů ƚŚǇƌŽŝĚĞĐƚŽŵǇ ĂŶĚ
central neck dissection at the first operation. I131 therapy was used in patients who had TT.  
Three patients had additional tumour foci in the thyroid. However, lymph node recurrence 
occurred in 2 patients at 6 and 16 months. At a median follow up of 55 months, all 6 patients 
were disease free. 
Conclusion:  
All patients with cancer in thyroglossal tract in this series had papillary thyroid cancer and 
did well with conventional treatment as for thyroid cancer. The extent of treatment required 
is debatable as only half the patients had additional foci in the thyroid and no patient had 
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clinically or radiologically involved lymph nodes at presentation. A systematic review of 
published cases will help summarise the existing knowledge base and clarify the similarities 
and differences with primary thyroid cancers. 
Keywords: Papillary thyroid carcinoma, Thyroglossal duct carcinoma, Thyroid cancer. 
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Introduction  
The thyroid descends from the floor of the pharynx to the anterior neck 
(1,2)
. Residual tissue 
along this path of migration is known as the thyroglossal duct or tract 
(2)
. This obliterates by 
the 10
th
 week of gestation, but may persist in some individuals 
(1)
. Accumulation of fluid 
resulting in cysts or residual thyroid tissue may be present anywhere along the path of 
descent from the floor of the mouth to the suprasternal notch 
(2)
. Approximately 67% of 
thyroglossal duct remnants are at the level of the hyoid bone; 33% suprahyoid, 13% 
suprasternal and 0.1% are intralingual 
(3)
.  
This developmental abnormality occurs in around 7% of the population 
(4)
. Of the people 
with a thyroglossal duct cyst, 1% develop a malignancy 
(4)
. The mean age at presentation is 6 
years in the paediatric population and a median of 38 years in the general population with 
an equal sex distribution 
(5)
. 
The cyst moves up with deglutition as it is closely associated with the hyoid bone 
(6,7)
.
 
Thyroglossal duct cysts are smooth, spherical, mobile and usually non tender, unless there is 
infection, which can result from pathogen transmission through the foramen cecum 
(2,8)
. 
Malignancy should be suspected if the lump is fixed, irregular and hard, especially in an older 
child 
(9)
. 
Clinically, there is no reliable way to distinguish between thyroglossal duct malignancies and 
benign cysts. Thyroglossal duct cancer generally affects women twice more often than men  
(10)
.
 
An irregular, hard mass, with invasion of local structures or suspicious lymphadenopathy 
may sometimes suggest malignancy 
(11)
. 
On ultrasound, thyroglossal cysts are anechoic or hypoechoic 
(11)
. The cancer may appear as 
a mural lesion within the cyst, sometimes associated with microcalcification 
(11)
. The most 
usual finding on computed tomography and magnetic resonance imaging is a solid nodule 
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within the cyst 
(11)
. Some authors recommend the routine use of fine needle aspiration 
cytology (FNAC) in all patients except children 
(1)
. This is particularly useful if the sample is 
positive for carcinoma 
(1)
.  However, even if up to 50% of such cancers can be diagnosed on 
FNAC, the low likelihood of malignancy in thyroglossal duct cysts (1%) reduces the utility and 
cost effectiveness of FNAC, especially in children 
(1,11-13)
. Given a higher rate of malignancy in 
a thyroglossal duct in the elderly and if the lesion has a solid component, FNAC may be 
considered in these instances 
(2)
. If malignancy is suspected during surgery, an intra-
operative frozen section can assist in diagnosis 
(14)
 and facilitate the performance of an 
adequate operation at the first surgery 
(12)
.
 
Symptomatic cysts, or those with a history of infection are managed by surgical excision 
(1,15)
. 
There are two commonly carried out procedures; simple cyst excision, or the more extensive 
^ŝƐƚƌƵŶŬ ?Ɛprocedure (1). dŚĞ^ŝƐƚƌƵŶŬ ?ƐŽƉĞƌĂƚŝŽŶŝŶǀŽůǀĞƐĂŶen bloc excision of the cyst with 
the tract and the mid-section of the hyoid bone 
(1)
. In a study, patients who underwent a 
simple excŝƐŝŽŶŚĂĚĂƌĞĐƵƌƌĞŶĐĞƌĂƚĞŽĨ ? ? ? ?йǁŚĞƌĞĂƐƉĂƚŝĞŶƚƐǁŚŽƵŶĚĞƌǁĞŶƚ^ŝƐƚƌƵŶŬ ?Ɛ
procedure had a recurrence rate of 5.3% 
(16)
. The overall recurrence rate was 9.7% 
(16)
.  
The majority of malignancies in thyroglossal duct cysts are papillary thyroid carcinomas; 
rarer types include follicular and squamous cancers. 
(2,11)
.
 
As thyroid parenchyma may be 
seen in around 2/3 of thyroglossal tracts, it is thought that papillary carcinomas develop de 
novo from the duct remnants rather than metastasize from primary tumours within the 
thyroid gland 
(11)
.
  
The features described for the diagnosis of a primary thyroglossal duct 
carcinoma arising from thyroid epithelium are that malignancy should not be present in the 
thyroid or any other primary site; the carcinoma should be within the wall of the 
thyroglossal duct remnant; the epithelial lining should be squamous or columnar; and 
normal thyroid follicles present within the thyroglossal duct remnant 
(17)
.
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Patients with papillary carcinoma of the thyroglossal duct have a very good prognosis - 
95.6% survival rate at 10 years 
(18)
. Patients with larger lesions and extensive metastases to 
the lymph nodes may benefit from radiotherapy 
(11)
.
 
The general consensus is that total thyroidectomy with the Sistrunk procedure should be 
performed in cases of differentiated thyroid cancer in the thyroglossal duct 
(11,18)
.
 
Some 
authors also advocate the performance of a prophylactic central compartment lymph node 
dissection at the time of thyroidectomy 
(19)
. However, due to the rarity of the disease, there 
is currently no strong evidence to support an optimal management strategy for thyroglossal 
duct carcinoma. Key questions include whether thyroidectomy and central neck dissection 
should be routinely performed and whether postoperative thyroid stimulating hormone 
suppression and/or radioactive iodine ablation are indicated in all cases 
(1,2,11)
.
  
The aim of this study is to present a series of patients with thyroglossal duct cancer and 
discuss the management strategies and clinical outcomes.
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Methods 
Of 637 patients diagnosed with thyroid cancer over a 15-year period, 5 patients (0.8%) with 
TGDCCa were identified. Another patient included in this series was diagnosed before this 15 
year period and was identified from hospital records. The medical records of the six patients 
were reviewed and information regarding demographics, presentation, diagnosis, 
management and outcomes was collected. The outcomes included data on biochemical, 
radiological and histologic evidence of recurrence. The analysis was primarily descriptive.  
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Results 
Table 1 presents the demographic details, presentation, methods of diagnosis, treatment 
details, staging and prognosis for all six patients treated for papillary thyroid cancer arising 
from the thyroglossal duct. The median (range) age of diagnosis was 41 (21-70) years. No 
patients had clinical evidence of lymph node involvement at presentation. At a median 
(range) follow up of 55 months (6 months to 29 years), all patients were free of disease. 
Case 1  
A 45 year old female patient with a 12 month history of neck lump, associated with 
discomfort and nausea. There was no significant past medical history or family history of 
thyroid disease. An ultrasound scan of the neck revealed a 1.5 cm solid, midline mass that 
moved on deglutition and tongue protrusion. A fine needle aspiration cytology from the 
lesion showed features suspicious of thyroid cancer (Thy4 cytology). The patient underwent 
^ŝƐƚƌƵŶŬ ?Ɛ ƉƌŽĐĞĚƵƌĞ ? &ƌŽǌĞŶ ƐĞĐƚŝŽŶ ĞǆĂŵŝŶĂƚŝŽŶ ĐŽŶĨŝƌŵĞĚ ƉĂƉŝůůĂƌǇ ƚŚǇƌŽŝĚ ĐĂŶĐĞƌ ĂŶĚ
therefore total thyroidectomy with central neck dissection was performed at the same 
procedure. Final histology demonstrated a 35 mm papillary cancer of the thyroglossal tract 
extending into adjacent skeletal muscle with clear resection margins. There was a further 2 
mm focus of papillary carcinoma in the right lobe of the thyroid gland, which was completely 
excised. None of the 14 lymph nodes identified were involved and excision margins were 
clear. Final histological staging was pT3(m)N0MxR0. 
Further treatment involved radio-iodine ablation (1.1 GBq I
131
) and TSH suppression therapy. 
At six months, the follow up radio-iodine scan was unremarkable. However, the stimulated 
thyroglobulin level was elevated at 6.9 ng/mL. A subsequent ultrasound scan identified a 1 
cm lymph node with micro calcification in level VI of the neck; FNA biopsy of which 
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confirmed residual papillary thyroid carcinoma. A CT scan showed no suggestion of disease 
elsewhere. A re-operative neck exploration and excision of this lesion was performed. Post-
operative laryngoscopy confirmed normal movement of vocal chords. 
Thyroglobulin levels were undetectable after the second operation and the patient is free of 
disease 44 months following her initial diagnosis.   
Case 2 
A 39 year old lady presented to her GP with a short history of a lump in the anterior neck. An 
ultrasound scan revealed a thyroglossal cyst and a normal sized thyroid gland. In view of the 
increasing size, the patient underwent a thyroglossal duct cyst excision. Histology 
demonstrated a 12 mm completely excised papillary thyroid carcinoma.  The patient 
underwent a total thyroidectomy. No further disease was identified in the thyroid. The 
pathological staging was pT1bNxR0. The patient underwent radioiodine ablation (3.76 GBq 
I
131
). She underwent TSH suppression for 5 years. The patient was well and free of disease 65 
months following diagnosis. 
Case 3  
A 21 year old woman presented with a swelling in her neck. A clinical diagnosis of 
ƚŚǇƌŽŐůŽƐƐĂů ĐǇƐƚ ǁĂƐ ŵĂĚĞ ? dŚĞ ƉĂƚŝĞŶƚ ƵŶĚĞƌǁĞŶƚ ^ŝƐƚƌƵŶŬ ?Ɛ ƉƌŽĐĞĚƵƌĞ ? ,ŝƐƚŽůŽŐǇ
demonstrated a 1 cm invasive papillary thyroid carcinoma. There was no vascular invasion or 
involvement of the hyoid bone. Five years after the initial surgery she had 1 lymph node 
removed that was benign. She did not have radioiodine ablation (as she did not undergo a 
thyroidectomy) but was treated with TSH suppression. She has remained well and disease 
free for 29 years now.  
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Case 4 
A 21 year old lady presented with a two month history of a swelling in the left 
submandibular area. Ultrasound and MRI demonstrated a complex cystic abnormality in the 
floor of the mouth extending down into the submandibular region. Excision of the cystic 
ŶŽĚƵůĞ ĂůŽŶŐǁŝƚŚ^ŝƐƚƌƵŶŬ ?ƐƉƌŽĐĞĚƵƌĞǁĂƐƉĞƌĨŽƌŵĞĚĂƐ ƚŚĞ ůĞƐŝŽŶǁĂƐǁƌĂƉƉĞĚĂƌŽƵŶĚ
hyoid bone. Histology revealed widely invasive papillary thyroid carcinoma in thyroglossal 
duct cyst with lymphovascular invasion. Following this, she went on to undergo total 
thyroidectomy; no further focus of carcinoma was identified. The tumour involved the 
circumferential margin. The final histology was pT3NxR1. She underwent radioiodine 
ablation therapy (1.1 GBq I
131
) and is on TSH suppression treatment. She developed lymph 
node metastases in both lateral compartments around 16 months after diagnosis and has 
had bilateral selective neck dissections following which she is currently disease free (21 
months after initial diagnosis).  
Case 5 
A 42 year old male presented with a midline lump in the neck. Following ultrasound scan, a 
diagnosis of thyroglossal cyst was made. The patient initially decided not to undergo surgery 
but due to increase in size of the cyst underwent cyst excision four years later. Histology 
showed thyroglossal cyst with a 17 mm non-invasive well differentiated papillary carcinoma. 
A further 1 mm focus of well differentiated follicular variant papillary carcinoma was present 
in the background. A total thyroidectomy was then performed and histology showed 
another 5 mm focus of completely excised well differentiated follicular variant papillary 
carcinoma in the superior pole of the right thyroid lobe. The overall staging was 
pT1(m)NxMxR0 papillary carcinoma of the thyroid. He underwent radioiodine ablation 
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therapy (3.7 GBq I
131
) and TSH suppression treatment. The patient remains disease free at 93 
months. 
Case 6 
A 70 year old female presented with a long standing submental 14-15mm mass. In addition, 
two benign appearing thyroid nodules were detected on ultrasound and on MRI, the 
submental mass appeared as an irregular soft tissue lesion. FNA showed indeterminate 
ĐǇƚŽůŽŐǇ  ?dŚǇ  ? ? ĂŶĚ ƚŚŝƐ ǁĂƐ ĨŽůůŽǁĞĚ ďǇ ^ŝƐƚƌƵŶŬ ?Ɛ ŽƉĞƌĂƚŝŽŶ ? ,ŝƐƚŽůŽŐǇ ĨƌŽŵ ^ŝƐƚƌƵŶŬ ?Ɛ
operation showed papillary thyroid cancer (21 mm mixture of classical and follicular variant 
papillary thyroid cancer) extending into the skeletal muscle (pT3). She subsequently 
underwent total thyroidectomy with central neck dissection. Multiple foci of classical 
papillary thyroid cancer were seen within the thyroid but no lymph nodes were involved. 
The overall staging was pT3(m)N0R0Mx. She later underwent radioiodine ablation (1.1GBq 
I
131
) and TSH suppression treatment. The patient remains disease free at 6 months after 
diagnosis.  
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Table 1 presents the demographic details, presentation, methods of diagnosis, treatment details, staging and prognosis for all five patients 
Age/ 
Sex 
Presentation Preoperative 
imaging 
Preoperative 
FNA 
Initial 
surgery 
Further 
treatment 
Histology Staging Recurrence Outcome 
(months 
between date of 
diagnosis and 
last known to 
be disease free)  
45 / F Neck lump 1.5 cm 
midline mass 
(USS) 
Thy4 ^ŝƐƚƌƵŶŬ ?Ɛ 
operation, 
TT and CND 
RIA (1.1 GBq I
131
) 
and TST 
Papillary thyroid 
carcinoma 
Further 2 mm 
focus of PTC in 
right thyroid lobe 
pT3(m)N0MxR0 Central 
compartment 
recurrence at 6 
months - had re-
operative surgery. 
Free of disease 
at 44 months 
39 / F Neck lump Thyroglossal 
cyst and 
normal 
thyroid (USS) 
Not done Thyroglossal 
duct cyst 
excision 
TT, RIA (3.76 GBq 
I
131
) and 
TST 
Papillary thyroid 
carcinoma 
pT1bNxR0 None Free of disease 
at 65 months 
21 / F Unknown Unknown Not done ^ŝƐƚƌƵŶŬ ?Ɛ
operation 
TST Papillary thyroid 
carcinoma  
Not available None Free of disease 
at 29 years 
21 / F Neck lump Complex 
cystic 
abnormality 
(MRI) 
Not done ^ŝƐƚƌƵŶŬ ?Ɛ
operation 
TT, RIA (1.1 GBq 
I
131
) and TST 
Papillary thyroid 
carcinoma 
pT3NxR1 Lateral 
compartment 
recurrence at 16 
months 
Free of disease 
at 21 months 
42/M Neck lump Thyroglossal 
cyst (USS) 
Not done Thyroglossal 
duct cyst 
excision 
TT, RIA (3.7 GBq 
I
131
) and  
TST 
Multifocal 
papillary thyroid 
carcinoma 
Further 5mm 
focus of PTC in 
right thyroid lobe 
pT1(m)NxMxR0 None Free of disease 
at 81 months 
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70/F Neck lump 1.5cm midline 
mass (USS 
and MRI) 
 
Thy 3  ^ŝƐƚƌƵŶŬ ?Ɛ
operation  
TT, CND, RIA 
(1.1GBq I
131
) and 
TST  
Papillary thyroid 
carcinoma 
(classical type and 
FVPTC)  
Multiple foci of 
classical PTC seen 
within the thyroid 
pT3(m)N0MxR0 
 
None Free of disease 
at 6 months 
Note: F  ? female; M  ? male; TT  ? total thyroidectomy; CND  ? central neck dissection; RIA  ? radioiodine ablation; TST  ? TSH suppression treatment; PTC  ? papillary thyroid 
carcinoma; FVPTC  ? follicular variant of PTC 
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Discussion  
In this case series, we describe our experience in managing 6 patients with this rare disease. 
All patients had papillary thyroid cancer, and although the management strategy has 
changed over the years for these patients, outcomes have been favourable. 
 
As described in table 1, initial surgical treatment and extent of surgery varied between cases 
in this series. A number of reasons underlie these differences. These include time of 
diagnosis (preoperative versus postoperative), extent of disease, changes in practice over 
the duration of study period, differences between clinicians and the lack of good evidence 
given the rarity of the disease.  
Thyroid malignancy arising from the thyroglossal duct is very rare and diagnoses are often  
made incidentally and postoperatively on histology 
(20)
. The majority of malignancies are 
papillary thyroid carcinomas 
(2,11,20)
. Clinicians debate about whether the origin of the 
tumour is a metastases from occult thyroid carcinoma or whether it is due to a malignant 
transformation of a remnant of thyroid tissue in the thyroglossal tract 
(21)
. In an autopsy 
study on 58 infants and children, 41.3% had remnants of the thyroglossal duct or ectopic 
thyroid 
(22)
. According to LiVolsi et al, papillary carcinoma in the thyroglossal duct most likely 
arises from islands of ectopic thyroid tissue adjacent to the cyst wall instead of the lining of 
the duct 
(23)
. 
Differences in opinion exist regarding whether patients with thyroglossal duct cyst 
carcinoma should undergo thyroidectomy. Some authors do not recommend a total 
thyroidectomy in low-risk patients with clinically and radiologically normal thyroid glands 
(1)
.  
These authors define low-risk patients as: age over 15 years and younger than 45 years, no 
history of radiation, <4cm diameter without soft tissue extension and/or distant metastases 
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(1,12)
.  Others have argued of a total thyroidectomy, especially if another focus in the thyroid 
cannot be ruled out 
(24)
. It is thought that 1.7%-7.6% of thyroglossal cysts contain thyroid 
tissue 
(20,25)
. Patients with clinically or radiologically abnormal regional lymph nodes require 
ĂŐŐƌĞƐƐŝǀĞƚƌĞĂƚŵĞŶƚŝŶĐůƵĚŝŶŐ^ŝƐƚƌƵŶŬ ?ƐƉƌŽĐĞĚƵƌĞ ?ƚŽƚĂůƚŚǇƌŽŝĚĞĐƚŽŵǇ ?ƌĂĚŝŽĂĐƚŝǀĞŝŽĚŝŶĞ
ablation followed by TSH suppression 
(20)
. The rationale for thyroidectomy in patients with a 
clinically normal thyroid is the increased risk (11-27%) of co-existing intraglandular thyroid 
cancer 
(1,5,26)
; facilitation of treatment with radio-iodine and monitoring for disease 
recurrence by measuring thyroglobulin levels
 (5)
. However, a thyroidectomy is associated 
with increased morbidity; complications include hypocalcaemia and recurrent laryngeal 
nerve injury 
(27)
. 
Therapeutic lymph node dissection of central and/or lateral compartments would be 
indicated on the basis of suspicious of pathological lymph nodes in the relevant part of the 
neck. However, the role of prophylactic lymph node dissection is controversial. Some 
suggest that, all patients should undergo TSH suppression whether they undergo 
thyroidectomy or not 
(20) 
and others propose TSH suppression as an alternative to 
thyroidectomy in low-risk adult patients 
(1)
. However, long term TSH suppression is 
associated with risks of osteoporosis and cardiovascular complications 
(28)
.
 
Currently, the TNM staging for thyroid cancer is applied for cancers arising from the thyroid 
epithelium of thyroglossal ducts 
(2)
. The validity of this is however unclear. Multiple foci of 
malignancy in the thyroid gland is denoted in the TNM stage by (m). It is unclear in TGDCCa 
whether a separate tumour focus in the thyroid should be considered as a multifocal 
tumour or a separate thyroid cancer. In addition, given the small size of thyroid epithelial 
remnants in TGDCCa, extension beyond the capsule often occurs and such tumours are 
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labelled pT3 regardless of size.  Due to its rarity, there is a lack of evidence to support the 
prognostic differences between the TNM stages in TGDCCa and any potential differences 
between TGDCCa and thyroid cancer of similar TNM stage.  
In our series, 2 in 6 patients displayed evidence of multifocality. One of these patients had 
recurrence in the central compartment of the neck despite having had a prophylactic central 
neck dissection at the first operation. The fourth patient in table 1 was diagnosed with 
bilateral lymph node recurrence in the lateral compartments and has had bilateral selective 
neck dissections. On this basis, we support the argument for total thyroidectomy, radio-
iodine ablation and TSH suppression in high risk patients. Given the lack of evidence, 
prophylactic lymph node of the central compartment may be performed in accordance to 
local practice in the management of thyroid cancer.  
This study is limited by its retrospective nature. In addition, given that patients have been 
included over a long time period and have been subject to different management strategies, 
it is difficult to draw conclusions on appropriateness of the treatments used.    
In summary, patients with papillary TGDCCa seem to do well with standard treatment in 
accordance to thyroid cancer guidelines. There are only a few published case reports and 
small series and this report adds to the evidence in literature. We recommend that a total 
thyroidectomy, radio-iodine ablation and TSH suppression treatment is considered in all 
patients with pT3 tumours and in those where imaging suggests further tumour foci in the 
thyroid. Prophylactic lymph node dissection is controversial but should be considered in 
high risk tumours in centres where the morbidity can be minimised. 
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A systematic review will help summarise the existing knowledge base and clarify the 
similarities and differences with primary thyroid cancers. Careful analyses of risk factors will 
help better stratification of risk categories and enable better tailoring of treatments. 
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